Gene: BTBD8
Official Full Name: BTB domain containing 8provided by HGNC
Gene Summary: Predicted to be involved in synaptic vesicle budding from endosome and synaptic vesicle endocytosis. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19354 | BTBD8 Knockout cell line (HCT 116) | Human | BTBD8 | 1:2~1:4 | Negative | Online Inquiry |
KO19355 | BTBD8 Knockout cell line (HEK293) | Human | BTBD8 | 1:3~1:6 | Negative | Online Inquiry |
KO19356 | BTBD8 Knockout cell line (A549) | Human | BTBD8 | 1:3~1:4 | Negative | Online Inquiry |
BTBD8 Gene Knockout Cell Lines represent a cutting-edge tool in genetic research and functional genomics, providing researchers with the ability to investigate the roles of the BTBD8 gene in various biological processes. These cell lines have been engineered to have a precise knockout of the BTBD8 gene, thereby allowing for the study of gene function, associated signaling pathways, and potential therapeutic targets in a controlled environment. By silencing this gene, researchers can elucidate its contributions to cellular homeostasis, disease mechanisms, and cellular responses to external stimuli.
The key mechanism behind these knockout cell lines lies in their CRISPR/Cas9 technology-based design, which enables the targeted disruption of the BTBD8 gene, leading to loss-of-function alterations. This precise genetic modification permits a robust analysis of phenotypic changes and molecular interactions that are critical for understanding BTBD8's role in cellular processes. In clinical and research contexts, these cell lines facilitate investigations into various diseases, including cancer and neurodegenerative disorders, where BTBD8 may play a significant role in disease progression or treatment response.
Compared to alternative models, BTBD8 Gene Knockout Cell Lines provide unique advantages, such as high specificity and reproducibility, allowing for more accurate experimental outcomes and reducing variability often seen in other models. This specificity enables a clearer dissection of gene function and interaction, thus accelerating the pace of research and discovery in pertinent scientific fields.
For researchers and clinicians alike, BTBD8 Gene Knockout Cell Lines are invaluable in driving innovative studies that may lead to revelations in therapeutic strategies and drug development. Their implementation could pave the way for breakthroughs in understanding complex diseases linked to the BTBD8 gene.
Our company prides itself on being at the forefront of genetic engineering and cell line development, with a proven track record of delivering high-quality biological products that empower the scientific community to achieve novel insights and advancements in research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.